Details for New Drug Application (NDA): 207465
✉ Email this page to a colleague
NDA 207465 describes METOPROLOL SUCCINATE, which is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Actavis Labs Fl Inc, Alkem Labs Ltd, Cipla, Dr Reddys Labs Ltd, Granules, Hetero Labs Ltd Iii, Ipca Labs Ltd, Lupin, Mylan Pharms Inc, Nesher Pharms, Novast Labs, Pharmadax, Prinston Inc, Reddys, Sandoz, Sunshine, Visum Pharm, Wockhardt Bio Ag, Yichang Humanwell, Zhejiang Jutai Pharm, and Zydus Pharms, and is included in twenty-eight NDAs. It is available from forty-three suppliers. Additional details are available on the METOPROLOL SUCCINATE profile page.
The generic ingredient in METOPROLOL SUCCINATE is metoprolol succinate. There is one drug master file entry for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the metoprolol succinate profile page.
The generic ingredient in METOPROLOL SUCCINATE is metoprolol succinate. There is one drug master file entry for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the metoprolol succinate profile page.
Summary for 207465
| Tradename: | METOPROLOL SUCCINATE |
| Applicant: | Cipla |
| Ingredient: | metoprolol succinate |
| Patents: | 0 |
Pharmacology for NDA: 207465
| Mechanism of Action | Adrenergic beta-Antagonists |
Suppliers and Packaging for NDA: 207465
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 207465 | ANDA | A-S Medication Solutions | 50090-6662 | 50090-6662-0 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6662-0) |
| METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 207465 | ANDA | A-S Medication Solutions | 50090-6662 | 50090-6662-1 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6662-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 50MG TARTRATE | ||||
| Approval Date: | Oct 26, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 100MG TARTRATE | ||||
| Approval Date: | Oct 26, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 200MG TARTRATE | ||||
| Approval Date: | Oct 26, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
